tiprankstipranks
Trending News
More News >
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (HK:1276)
:1276
Hong Kong Market

Compare Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H (1276) vs. Competitors

Compare
3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
HK$68.45
HK$432.07B
58.89
24.12%
2 Buy
0 Hold
0 Sell
Moderate Buy
CSPC Pharmaceutical Group
$1.20
$14.14B
25.86
103.39%
12 Buy
1 Hold
3 Sell
Moderate Buy
Wuxi Biologics (Cayman)
$4.28
$19.58B
29.90
80.89%
3 Buy
0 Hold
0 Sell
Strong Buy
WuXi AppTec Co., Ltd. Class H
HK$113.60
HK$314.39B
19.89
101.45%
4 Buy
0 Hold
0 Sell
Strong Buy
Hansoh Pharmaceutical Group Company Limited
HK$38.60
HK$233.73B
44.46
115.88%
3 Buy
0 Hold
0 Sell
Strong Buy
BeiGene Ltd
HK$206.60
HK$330.92B
664.31
49.49%
13 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:1276
Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H
68.45
14.75
27.47%
CHJTF
CSPC Pharmaceutical Group
1.20
0.64
113.52%
WXIBF
Wuxi Biologics (Cayman)
4.28
1.91
80.51%
HK:2359
WuXi AppTec Co., Ltd. Class H
111.20
57.07
105.43%
HK:3692
Hansoh Pharmaceutical Group Company Limited
38.60
21.00
119.32%
HK:6160
BeiGene Ltd
206.60
71.60
53.04%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts